Y. Eralp Et Al. , "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer," ANNALS OF ONCOLOGY , vol.19, no.4, pp.669-674, 2008
Eralp, Y. Et Al. 2008. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. ANNALS OF ONCOLOGY , vol.19, no.4 , 669-674.
Eralp, Y., Derin, D., Ozluk, Y., Yavuz, E., Guney, N., Saip, P., ... Muslumanoglu, M.(2008). MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. ANNALS OF ONCOLOGY , vol.19, no.4, 669-674.
Eralp, Y. Et Al. "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer," ANNALS OF ONCOLOGY , vol.19, no.4, 669-674, 2008
Eralp, Y. Et Al. "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer." ANNALS OF ONCOLOGY , vol.19, no.4, pp.669-674, 2008
Eralp, Y. Et Al. (2008) . "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer." ANNALS OF ONCOLOGY , vol.19, no.4, pp.669-674.
@article{article, author={Y. Eralp Et Al. }, title={MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer}, journal={ANNALS OF ONCOLOGY}, year=2008, pages={669-674} }